UAE – GluCare.Health has expanded its product offerings with the launch of its new Testosterone Replacement Therapy (TRT) program.
GluCare.Health’s virtual TRT program has pioneered complex telehealth processes involving analyzing blood biomarkers that result in prescription medications specifically formulated for each patient.
In a press release, GluCare.Health said: “Our Testosterone Replacement Therapy program is the first to be implemented completely virtually in the United Arab Emirates.”
Based in the Emirate of Dubai, GluCare.Health is the first hybrid Digital Therapeutics (DTx)+Human vertically integrated metabolic disease platform of its kind.
The addition of the virtual TRT program to the GluCare.Health offerings bolster the platform’s capabilities in tackling the global metabolic health crisis.
On account of this, the latest offering was developed for people with low testosterone levels, which is a significant health concern affecting a substantial number of men worldwide.
GluCare.Health aims to address a long-standing taboo issue and provide a transformative solution for men with low testosterone in a seamless and hyper-personalized way.
The program provides virtual consultations, testing, medication delivery, and administration using an integrated team of urologists and endocrinologists that develop personalized treatment plans tailored to each individual’s specific needs.
This program follows hugely successful subscription models around diabetes under GluCare Health and Obesity under Zone Health.
On his part, Dr. Ihsan Almarzooqi, Managing Director at GluCare.Health stated: “Our virtual TRT program has been developed to provide end-to-end care, starting from comprehensive testing, medication selection, and delivery, and continuous engagement delivered seamlessly for an affordable monthly fee.”
GluCare.Health seeks to improve the signs and symptoms of low testosterone in these men through a mix of lifestyle interventions and weight loss strategies.
According to recent studies, it is estimated that approximately 45% of men over the age of 40 experience low testosterone levels, also known as hypogonadism.
In the UAE alone, statistics indicate a rising trend of men facing this hormonal imbalance, impacting their overall well-being, physical health, and quality of life.
GluCare.Health’s virtual TRT program is designed to revolutionize men’s health by offering a convenient and accessible solution.
Commenting on this innovative solution, Dr. Ihsan Almarzooqi noted: “Evolving out of the renowned GluCare holistic model of care, our team recognized how frustrated men were with the existing treatment options for the hormone replacement therapy that usually accompanies metabolic disorders or age.”
The program has pioneered complex telehealth processes involving analyzing blood biomarkers that result in prescription medications delivered to the home, bypassing a fragmented healthcare ecosystem that lacks coordination and can take months to arrive at a similar care plan.
The launch of the TRT program exemplifies GluCare.Health’s commitment to delivering innovative and highly personalized ‘continuous healthcare’ approaches that provides a comprehensive and real-time view of patients.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
